Abstract
Stable coronary artery disease (CAD) is a clinical entity of great epidemiological importance. It is becoming increasingly common due to the longer life expectancy, being strictly related to age and to advances in diagnostic techniques and pharmacological and non-pharmacological interventions. Stable CAD encompasses a variety of clinical and anatomic presentations, making the identification of its clinical and anatomical features challenging. Therapeutic interventions should be defined on an individual basis according to the patient's risk profile. To this aim, management flow charts have been reviewed based on sustainability and appropriateness derived from recent evidence. Special emphasis has been placed on non-pharmacological interventions, stressing the importance of lifestyle changes, including smoking cessation, regular physical activity, and diet. Adherence to therapy as an emerging risk factor is also discussed.
| Original language | English |
|---|---|
| Pages (from-to) | D163-D189 |
| Number of pages | 26 |
| Journal | European Heart Journal, Supplement |
| Volume | 19 |
| Issue number | Suppl D |
| DOIs | |
| Publication status | Published - May 2017 |
Fingerprint
Keywords
- Journal Article
Cite this
ANMCO/GICR-IACPR/SICI-GISE Consensus Document : the clinical management of chronic ischaemic cardiomyopathy. / Riccio, Carmine; Gulizia, Massimo Michele; Colivicchi, Furio; Lenarda, Andrea Di; Musumeci, Giuseppe; Faggiano, Pompilio Massimo; Abrignani, Maurizio Giuseppe; Rossini, Roberta; Fattirolli, Francesco; Valente, Serafina; Mureddu, Gian Francesco; Temporelli, Pierluigi; Olivari, Zoran; Amico, Antonio Francesco; Casolo, Giancarlo; Fresco, Claudio; Menozzi, Alberto; Nardi, Federico.
In: European Heart Journal, Supplement, Vol. 19, No. Suppl D, 05.2017, p. D163-D189.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - ANMCO/GICR-IACPR/SICI-GISE Consensus Document
T2 - the clinical management of chronic ischaemic cardiomyopathy
AU - Riccio, Carmine
AU - Gulizia, Massimo Michele
AU - Colivicchi, Furio
AU - Lenarda, Andrea Di
AU - Musumeci, Giuseppe
AU - Faggiano, Pompilio Massimo
AU - Abrignani, Maurizio Giuseppe
AU - Rossini, Roberta
AU - Fattirolli, Francesco
AU - Valente, Serafina
AU - Mureddu, Gian Francesco
AU - Temporelli, Pierluigi
AU - Olivari, Zoran
AU - Amico, Antonio Francesco
AU - Casolo, Giancarlo
AU - Fresco, Claudio
AU - Menozzi, Alberto
AU - Nardi, Federico
PY - 2017/5
Y1 - 2017/5
N2 - Stable coronary artery disease (CAD) is a clinical entity of great epidemiological importance. It is becoming increasingly common due to the longer life expectancy, being strictly related to age and to advances in diagnostic techniques and pharmacological and non-pharmacological interventions. Stable CAD encompasses a variety of clinical and anatomic presentations, making the identification of its clinical and anatomical features challenging. Therapeutic interventions should be defined on an individual basis according to the patient's risk profile. To this aim, management flow charts have been reviewed based on sustainability and appropriateness derived from recent evidence. Special emphasis has been placed on non-pharmacological interventions, stressing the importance of lifestyle changes, including smoking cessation, regular physical activity, and diet. Adherence to therapy as an emerging risk factor is also discussed.
AB - Stable coronary artery disease (CAD) is a clinical entity of great epidemiological importance. It is becoming increasingly common due to the longer life expectancy, being strictly related to age and to advances in diagnostic techniques and pharmacological and non-pharmacological interventions. Stable CAD encompasses a variety of clinical and anatomic presentations, making the identification of its clinical and anatomical features challenging. Therapeutic interventions should be defined on an individual basis according to the patient's risk profile. To this aim, management flow charts have been reviewed based on sustainability and appropriateness derived from recent evidence. Special emphasis has been placed on non-pharmacological interventions, stressing the importance of lifestyle changes, including smoking cessation, regular physical activity, and diet. Adherence to therapy as an emerging risk factor is also discussed.
KW - Journal Article
U2 - 10.1093/eurheartj/sux021
DO - 10.1093/eurheartj/sux021
M3 - Article
C2 - 28533729
VL - 19
SP - D163-D189
JO - European Heart Journal, Supplement
JF - European Heart Journal, Supplement
SN - 1520-765X
IS - Suppl D
ER -